Showing results (11-20 of 48) with videos related to
Sort By:
Pageof 5
Cellular Immunology|April 15, 1993
Enhancing effects of autologous erythrocytes on human or mouse cytokine secretion and IL-2R expressionY Kalechman, S Herman, U Gafter, et al.Journal of Clinical Immunology|March 1, 1990
The effect of a single whole-blood transfusion on cytokine secretionY Kalechman, U Gafter, D Sobelman, et al.Immunopharmacology|March 1, 1995
Induction of acute phase proteins in mice and humans by treatment with AS101, an immunomodulator with radioprotective propertiesY Kalechman, A Shani, M Albeck, et al.Experimental Hematology|December 1, 1992
The effect of AS101 on the reconstitution of T-cell reactivity following irradiation or cyclophosphamide treatmentY Kalechman, I Sotnik-Barkai, M Albeck, et al.Research Communications in Molecular Pathology and Pharmacology|January 1, 1995
The cytoprotective effect of the immunomodulator AS101 against hydrochloride induced gastric lesionsR H Xu, Y Kalechman, M Albeck, et al.Clinical and Experimental Immunology|May 1, 1994
Modulation of the IL-2 production defect in vitro in Graves' diseaseZ Eisenstein, E Engelsman, M Weiss, et al.Experimental Hematology|November 1, 1990
Enhancing effect of cyclosporins A and G on bone marrow colony formationY Kalechman, B Sredni, R R Caspi, et al.Immunology|March 1, 1977
Colony growth in vitro of mitogen-stimulated mouse B lymphocytesL A Rozenszajn, H Michlin, Y Kalechman, et al.Cancer Research|April 15, 1993
Protection of bone marrow stromal cells from the toxic effects of cyclophosphamide in vivo and of ASTA-Z 7557 and etoposide in vitro by ammonium trichloro(dioxyethylene-O-O')tellurate (AS101)Y Kalechman, I Sotnik-Barkai, M Albeck, et al.Experimental Hematology|December 1, 1995
Effect of the immunomodulator AS101 on chemotherapy-induced multilineage myelosuppression, thrombocytopenia, and anemia in miceY Kalechman, G Rushkin, J Nerubay, et al.Pageof 5